Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Dro
 

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensitive detection of multiple genomic markers focused on oncology applications, utilizing Bio-Rad's Droplet Digital? PCR (ddPCR?) technology on Bio-Rad's QX600 platform.

More...